These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31512778)

  • 1. The potential role of regulatory microRNAs of RAS/MAPK signaling pathway in the pathogenesis of colorectal cancer.
    Soleimani A; Rahmani F; Saeedi N; Ghaffarian R; Khazaei M; Ferns GA; Avan A; Hassanian SM
    J Cell Biochem; 2019 Dec; 120(12):19245-19253. PubMed ID: 31512778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer.
    Rahmani F; Avan A; Hashemy SI; Hassanian SM
    J Cell Physiol; 2018 Feb; 233(2):811-817. PubMed ID: 28266708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal Cancer.
    Soleimani A; Rahmani F; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
    Curr Pharm Des; 2018; 24(39):4605-4610. PubMed ID: 30636581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action.
    Masliah-Planchon J; Garinet S; Pasmant E
    Oncotarget; 2016 Jun; 7(25):38892-38907. PubMed ID: 26646588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma.
    Poenitzsch Strong AM; Setaluri V; Spiegelman VS
    Arch Biochem Biophys; 2014 Dec; 563():118-24. PubMed ID: 25043973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Long Non-Coding RNA FGF14-AS2 Inhibits Colorectal Cancer Proliferation Via the RERG/Ras/ERK Signaling by Sponging microRNA-1288-3p.
    Hou R; Liu Y; Su Y; Shu Z
    Pathol Oncol Res; 2020 Oct; 26(4):2659-2667. PubMed ID: 32654025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.
    Ye YP; Wu P; Gu CC; Deng DL; Jiao HL; Li TT; Wang SY; Wang YX; Xiao ZY; Wei WT; Chen YR; Qiu JF; Yang RW; Lin J; Liang L; Liao WT; Ding YQ
    Oncotarget; 2016 Sep; 7(38):61312-61324. PubMed ID: 27494869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
    Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
    Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis.
    Guo Y; Bao Y; Yang W
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28441730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High expression of fragile X mental retardation protein inhibits ferroptosis of colorectal tumor cells by activating the RAS/MAPK signaling pathway].
    Wang N; Shi B; Man X; Wu W; Cao J
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):885-893. PubMed ID: 38862446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1.
    Yin Y; Yan ZP; Lu NN; Xu Q; He J; Qian X; Yu J; Guan X; Jiang BH; Liu LZ
    Biochim Biophys Acta; 2013 Feb; 1829(2):239-47. PubMed ID: 23201159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.
    Benvenuti S; Sartore-Bianchi A; Di Nicolantonio F; Zanon C; Moroni M; Veronese S; Siena S; Bardelli A
    Cancer Res; 2007 Mar; 67(6):2643-8. PubMed ID: 17363584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7.
    Li X; Wang J; Zhang C; Lin C; Zhang J; Zhang W; Zhang W; Lu Y; Zheng L; Li X
    J Pathol; 2018 Oct; 246(2):166-179. PubMed ID: 29943828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships among
    Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
    World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orai1, a Direct Target of microRNA-519, Promotes Progression of Colorectal Cancer via Akt/GSK3β Signaling Pathway.
    Deng W; Wang J; Zhang J; Cai J; Bai Z; Zhang Z
    Dig Dis Sci; 2016 Jun; 61(6):1553-60. PubMed ID: 26792278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA interaction with MAPK and AKT pathways in paediatric brain tumours - preliminary results and review of the literature.
    Gruszka R; Zakrzewski K; Liberski PP; Zakrzewska M
    Folia Neuropathol; 2020; 58(2):123-132. PubMed ID: 32729291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.
    Kent OA; Fox-Talbot K; Halushka MK
    Oncogene; 2013 May; 32(20):2576-85. PubMed ID: 22751122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
    Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
    Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J; Chen Q
    FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer.
    Jacobsen A; Bosch LJW; Martens-de Kemp SR; Carvalho B; Sillars-Hardebol AH; Dobson RJ; de Rinaldis E; Meijer GA; Abeln S; Heringa J; Fijneman RJA; Feenstra KA
    Sci Rep; 2018 May; 8(1):7522. PubMed ID: 29760449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.